HubSpot Announces Date of Fourth Quarter and Full Year 2021 Financial Results Release Cambridge, Business
Caraway Therapeutics Receives Third Research Grant from The Michael J. Fox Foundation to Continue Advancement of TRPML1 Agonists for GBA-Parkinson's Disease Cambridge, Business
Guardicore and Medigate Provide Zero Trust-enabled Ransomware Mitigation USA - English USA - English Cambridge, Business
Harbour BioMed Announces Dosing of First Patient in Combination Therapy Phase Ib/IIa Trial of Next-Generation Anti-CTLA-4 Antibody Cambridge, Business
New England Journal of Medicine Publishes Data from ECOSPOR lll Phase 3 Study Evaluating Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection Cambridge, Business
Modo Labs Acquires Integration Experts RojoServe to Accelerate Hybrid Workplace and Digital Campus Transformation Cambridge, Business
Akamai Comments on National Security Council and White House Open Source Software Security Summit Cambridge, Business
Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates Cambridge, Business
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates Cambridge, Business
Nuvalent Announces First Patient Dosed in ARROS-1 Phase 1/2 Clinical Trial of NVL-520, its Novel ROS1-selective Inhibitor Cambridge, Business
Amylyx Pharmaceuticals Announces Pricing of Upsized Initial Public Offering of Common Stock Cambridge, Business
Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003 Cambridge, Business